NCAM1 and neuroblastoma: Based on label-free proteomic analyses, multiple cell surface proteins including NCAM1, L1CAM, EMMPRIN (CD147), ITGB1, ITGAV, and CNTFR, which were well characterized in other cancer types, were also considered as potential targets for NB treatment.